Grifols, S.A. GRFS
$ 8.4
-2.33%
Annual report 2023
added 11-16-2024
Country |
Spain |
IPO year |
- |
Industry |
Drug manufacturers |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Raimon Grifols Roura |
Employees in the company |
24 000 |
Shares |
- |
Market Cap[1] |
$ 6.83 B |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.